TARG-10

N/A

Report date: 2025/01/26 17:10:54

Base Information

Drug NameTARG-10
Drug Alias Nameintegrin alpha-10/beta-1 modulator (Targinta)TARG-10
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionIntegrin alpha-4/beta-1 modulators
TargetsIntegrin alpha-4/beta-1
Therapy Area/IndicationsNeoplasm MetastasisTriple Negative Breast NeoplasmsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryEuropeSweden
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTarginta AB
China Registration ClassN/A

Develop Information

Active CompaniesTarginta AB
Inactive CompaniesN/A
Active IndicationsNeoplasm MetastasisTriple Negative Breast NeoplasmsGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A